FDG-PET/CT aids assessment of lower-stage breast cancer
June 29, 2016 -- FDG-PET/CT's ability to find a significant number of distant metastases in patients with newly diagnosed clinical stage IIB triple-negative breast cancer suggests that current guidelines from the National Comprehensive Cancer Network for the modality's use may need to be revised.
Prostate radiotracer may benefit breast cancer imaging
June 24, 2016 -- A radiotracer recently cleared for PET imaging of recurrent prostate cancer may have similar efficacy for certain forms of breast cancer, according to a study presented at last week's Society of Nuclear Medicine and Molecular Imaging meeting.
Novel PET combination awarded SNMMI Image of the Year
June 15, 2016 -- SAN DIEGO - German researchers have received this year's Image of the Year award from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for the use of three different radiotracers with PET to measure amyloid plaques, tau tangles, and metabolic activity in the brains of living Alzheimer's patients.
SNMMI: FDG-PET predicts breast cancer outcomes
June 15, 2016 -- SAN DIEGO - FDG-PET is a considerably better predictor of treatment response and outcome than fluoride-PET for breast cancer patients with metastatic bone lesions, concluded researchers on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
SNMMI: PET shows tau may be Alzheimer's catalyst
June 14, 2016 -- SAN DIEGO - In a comparison of PET images with three different radiotracers, German researchers found that tau deposits may be more influential in causing Alzheimer's disease than amyloid accumulation, according to results presented on Monday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.
SNMMI: PiB-PET finds unique Down syndrome trait
June 13, 2016 -- SAN DIEGO - Using carbon-11-labeled Pittsburgh Compound B (PiB) with PET, researchers have tracked an unusual increase in beta-amyloid plaque in the striatum region of the brain among people with Down syndrome, according to a study presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
Michael J. Fox Foundation launches $2M PET tracer prize
June 13, 2016 -- The Michael J. Fox Foundation will award a $2 million prize for the development of a PET tracer to visualize alpha-synuclein, a key protein in Parkinson's disease. The foundation made its announcement at the 2016 Society of Nuclear Medicine and Molecular Imaging meeting in San Diego.
Mammi-PET finds tiny breast lesions -- but could improve
June 2, 2016 -- A new dedicated positron emission mammography (PEM) device was put through its paces by European researchers in an article in the June issue of the American Journal of Roentgenology. While the PEM system excelled at identifying lesions smaller than 1 cm, its limited field-of-view could be an issue, they found.
FDA approves Blue Earth PET agent for prostate cancer
May 27, 2016 -- The U.S. Food and Drug Administration (FDA) has approved a new PET radiopharmaceutical from Blue Earth Diagnostics for detecting recurrent prostate cancer.
Correct coding and reimbursement for hepatobiliary scans
May 27, 2016 -- What are the correct coding procedures for nuclear medicine hepatobiliary scans? If you're not sure, don't worry -- Donna Richmond from Panacea Healthcare Solutions is here to help with her latest column.